Hematopoietic cell lineage |
95 |
7.1 |
27 |
6.64E-10 |
1.46E-07 |
B cell receptor signaling pathway |
72 |
5.38 |
23 |
9.83E-10 |
1.46E-07 |
Primary immunodeficiency |
36 |
2.69 |
16 |
1.40E-09 |
1.46E-07 |
Protein processing in endoplasmic reticulum |
163 |
12.2 |
30 |
3.07E-06 |
0.000241 |
T cell receptor signaling pathway |
101 |
7.55 |
22 |
3.85E-06 |
0.000242 |
Calcium signaling pathway |
189 |
14.1 |
30 |
6.11E-05 |
0.0032 |
NF-kappa B signaling pathway |
109 |
8.14 |
20 |
0.000141 |
0.00607 |
Cell adhesion molecules (CAMs) |
171 |
12.8 |
27 |
0.000155 |
0.00607 |
Epstein-Barr virus infection |
230 |
17.2 |
33 |
2.00E-04 |
0.00696 |
Antigen processing and presentation |
91 |
6.8 |
17 |
0.000351 |
0.011 |
Chemokine signaling pathway |
200 |
14.9 |
29 |
0.000401 |
0.0114 |
AGE-RAGE signaling pathway in diabetic complications |
101 |
7.55 |
18 |
0.000434 |
0.0114 |
Fc gamma R-mediated phagocytosis |
87 |
6.5 |
16 |
0.000622 |
0.015 |
Leukocyte transendothelial migration |
115 |
8.59 |
19 |
0.000808 |
0.0181 |
Leishmaniasis |
67 |
5.01 |
13 |
0.00118 |
0.0232 |
Jak-STAT signaling pathway |
165 |
12.3 |
24 |
0.00118 |
0.0232 |
HIF-1 signaling pathway |
105 |
7.85 |
17 |
0.00188 |
0.0347 |
EGFR tyrosine kinase inhibitor resistance |
80 |
5.98 |
14 |
0.00219 |
0.0382 |
Toxoplasmosis |
108 |
8.07 |
17 |
0.00256 |
0.0418 |
Natural killer cell mediated cytotoxicity |
118 |
8.82 |
18 |
0.00277 |
0.0418 |
Non-small cell lung cancer |
66 |
4.93 |
12 |
0.00319 |
0.0418 |
Legionellosis |
58 |
4.33 |
11 |
0.00333 |
0.0418 |
Arginine and proline metabolism |
50 |
3.74 |
10 |
0.00337 |
0.0418 |
ErbBsignaling pathway |
84 |
6.28 |
14 |
0.00349 |
0.0418 |
Th17 cell differentiation |
102 |
7.62 |
16 |
0.0035 |
0.0418 |
Focal adhesion |
199 |
14.9 |
26 |
0.00355 |
0.0418 |
Pathways in cancer |
535 |
40 |
57 |
0.00363 |
0.0418 |
Mucin type O-glycan biosynthesis |
28 |
2.09 |
7 |
0.00372 |
0.0418 |
Intestinal immune network for IgA production |
43 |
3.21 |
9 |
0.00387 |
0.0419 |
Cytokine-cytokine receptor interaction |
296 |
22.1 |
35 |
0.00433 |
0.0453 |
Measles |
144 |
10.8 |
20 |
0.00503 |
0.051 |
NOD-like receptor signaling pathway |
206 |
15.4 |
26 |
0.00565 |
0.0539 |
Longevity regulating pathway - multiple species |
62 |
4.63 |
11 |
0.00567 |
0.0539 |
GABAergic synapse |
90 |
6.73 |
14 |
0.00658 |
0.0608 |
Pancreatic cancer |
75 |
5.6 |
12 |
0.00917 |
0.0823 |
Glutamatergic synapse |
114 |
8.52 |
16 |
0.0104 |
0.0899 |
Regulation of actin cytoskeleton |
217 |
16.2 |
26 |
0.011 |
0.0899 |
Platinum drug resistance |
77 |
5.75 |
12 |
0.0113 |
0.0899 |
Platelet activation |
125 |
9.34 |
17 |
0.0114 |
0.0899 |
Prion diseases |
34 |
2.54 |
7 |
0.0115 |
0.0899 |
Th1 and Th2 cell differentiation |
87 |
6.5 |
13 |
0.012 |
0.0922 |
Rap1 signaling pathway |
209 |
15.6 |
25 |
0.0127 |
0.0931 |
Glycosphingolipid biosynthesis - lacto and neolacto series |
27 |
2.02 |
6 |
0.013 |
0.0931 |
Carbohydrate digestion and absorption |
43 |
3.21 |
8 |
0.013 |
0.0931 |
Osteoclast differentiation |
128 |
9.56 |
17 |
0.0142 |
0.0992 |
Axon guidance |
180 |
13.5 |
22 |
0.0148 |
0.101 |
Protein digestion and absorption |
90 |
6.73 |
13 |
0.0158 |
0.105 |
PI3K-Akt signaling pathway |
358 |
26.8 |
38 |
0.017 |
0.111 |
MAPK signaling pathway |
294 |
22 |
32 |
0.0196 |
0.126 |
Alanine, aspartate and glutamate metabolism |
38 |
2.84 |
7 |
0.0208 |
0.13 |
Estrogensignaling pathway |
134 |
10 |
17 |
0.0216 |
0.133 |
Sphingolipid metabolism |
48 |
3.59 |
8 |
0.0245 |
0.148 |
Rassignaling pathway |
233 |
17.4 |
26 |
0.0252 |
0.148 |
Amoebiasis |
106 |
7.92 |
14 |
0.0257 |
0.148 |
Nicotine addiction |
40 |
2.99 |
7 |
0.027 |
0.148 |
VEGF signaling pathway |
58 |
4.33 |
9 |
0.027 |
0.148 |
Endometrial cancer |
58 |
4.33 |
9 |
0.027 |
0.148 |
Glycosphingolipid biosynthesis - globo and isoglobo series |
16 |
1.2 |
4 |
0.0273 |
0.148 |
Prostate cancer |
97 |
7.25 |
13 |
0.0278 |
0.148 |
Renal cell carcinoma |
68 |
5.08 |
10 |
0.0286 |
0.15 |
Inflammatory bowel disease (IBD) |
59 |
4.41 |
9 |
0.0298 |
0.154 |
Fluid shear stress and atherosclerosis |
143 |
10.7 |
17 |
0.0375 |
0.187 |
IL-17 signaling pathway |
91 |
6.8 |
12 |
0.0376 |
0.187 |
Small cell lung cancer |
92 |
6.87 |
12 |
0.0404 |
0.196 |
Adherens junction |
72 |
5.38 |
10 |
0.0405 |
0.196 |
Cholinergic synapse |
113 |
8.44 |
14 |
0.0415 |
0.197 |
Chagas disease (American trypanosomiasis) |
103 |
7.7 |
13 |
0.0426 |
0.198 |
Sphingolipid signaling pathway |
124 |
9.27 |
15 |
0.0428 |
0.198 |
Thyroid hormone signaling pathway |
115 |
8.59 |
14 |
0.047 |
0.213 |
Gastric acid secretion |
74 |
5.53 |
10 |
0.0475 |
0.213 |
Phagosome |
181 |
13.5 |
20 |
0.0497 |
0.22 |